Indacaterol/glycopyrronium/mometasone furoate (Enerzair Breezhaler®) accepted for use within NHSScotland

This is recommended as maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting beta2-agonist and a high dose of an inhaled corticosteroid who experienced ≥1 asthma exacerbations in the previous year.

Scottish Medicines Consortium